votoplam — FDA meeting
2H 2026
Plan to engage with FDA in 2H 2026 to discuss PIVOT-HD 24-month results being finalizedSource filing
PTC THERAPEUTICS INC · Data as of 2026-09-08
2H 2026
Plan to engage with FDA in 2H 2026 to discuss PIVOT-HD 24-month results being finalizedSource filing
Q4 2026
BLA submission expected to be completed in Q4 2026 with potential for commercial launch in 2027 –Source filing